Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- LUNG
- Price
- 5.25
- Stock movement up
- +0.04 (0.77%)
- Company name
- Pulmonx Corp
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Medical Devices
- Market cap
- 207.31M
- Ent value
- 217.48M
- Price/Sales
- 2.61
- Price/Book
- 2.21
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 12.42%
- 1 year return
- -36.90%
- 3 year return
- -40.87%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-04-12
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
LUNG does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 2.61 |
| Price to Book | 2.21 |
| EV to Sales | 2.74 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 39.49M |
| EPS (TTM) | -1.45 |
| FCF per share (TTM) | -0.89 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 79.30M |
| Gross profit (TTM) | 58.61M |
| Operating income (TTM) | -56.49M |
| Net income (TTM) | -57.11M |
| EPS (TTM) | -1.45 |
| EPS (1y forward) | -1.58 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 73.91% |
| Operating margin (TTM) | -71.23% |
| Profit margin (TTM) | -72.01% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 63.31M |
| Net receivables | 12.32M |
| Total current assets | 140.93M |
| Goodwill | 2.33M |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 167.40M |
| Accounts payable | 4.58M |
| Short/Current long term debt | 55.81M |
| Total current liabilities | 18.30M |
| Total liabilities | 73.48M |
| Shareholder's equity | 93.92M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -33.26M |
| Capital expenditures (TTM) | 1.54M |
| Free cash flow (TTM) | -34.79M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -60.80% |
| Return on Assets | -34.11% |
| Return on Invested Capital | -59.89% |
| Cash Return on Invested Capital | -36.49% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 5.22 |
| Daily high | 5.48 |
| Daily low | 5.05 |
| Daily Volume | 392K |
| All-time high | 69.02 |
| 1y analyst estimate | 11.92 |
| Beta | 0.68 |
| EPS (TTM) | -1.45 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 29 Apr 2025 |
Downside potential
Loading...
Downside potential data
| LUNG | S&P500 | |
| Current price drop from All-time high | -92.39% | -12.89% |
| Highest price drop | -93.02% | -56.47% |
| Date of highest drop | 4 Nov 2022 | 9 Mar 2009 |
| Avg drop from high | -67.91% | -11.07% |
| Avg time to new high | 76 days | 12 days |
| Max time to new high | 1075 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
207.31M
Marketcap category
Small-cap
Description
Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Employees
279
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page